Thomas Ciulla - Chief Medical Officer at Viridian Therapeutics, Inc.\DE

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
VRDN on Nasdaq
Industry
Services-Medical Laboratories
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Thomas Ciulla since 11/5/2023

Holdings reported by Thomas Ciulla for Viridian Therapeutics, Inc.\DE

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 762 $16K $21.00 Jan 3, 2024 Direct
Stock Option (Right to Buy) 50K Feb 5, 2024 Direct Common Stock

Transactions reported by Thomas Ciulla for Viridian Therapeutics, Inc.\DE

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.